ELTX EPS Estimates
Elicio Therapeutics, Inc.
$1.79
+$0.02(+1.13%)
28
Overall
40
Value
18
Tech
26
Quality
Market Cap
$48.49M
Volume
373.25K
52W Range
$1.71 - $16.00
Target Price
$14.38
ELTX EPS estimates: the consensus estimate for Elicio Therapeutics, Inc.'s current fiscal year is -$1.90 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ELTX EPS Estimates
- EPS estimate, current quarter
- $-0.42
- EPS estimate, next quarter
- $-0.34
- EPS estimate, current year
- $-1.90
- EPS estimate, next year
- $-1.74
- EPS growth, 3-year
- +41.52%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.58 |
| 2024 | $-4.25 |
| 2023 | $-6.96 |
| 2022 | $-12.90 |
| 2021 | $-19.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELTX | $1.79 | +1.1% | 373.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Elicio Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW